---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-009992"
form_type: "8-K"
ticker: "IBIO"
cik: "0001420720"
company_name: "iBio, Inc."
filed_at: "2025-08-01T23:59:59+00:00"
generated_at: "2026-05-17T21:47:46.750765+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# iBio receives Nasdaq deficiency notice for bid price below $1.00, has 180 days to cure

## Summary
- Received Nasdaq notice on July 29, 2025 for failing Minimum Bid Price of $1.00 for 30 consecutive business days.
- Company has until January 26, 2026 to regain compliance by closing at $1.00+ for at least 10 consecutive business days.
- If not cured, iBio may be eligible for additional 180 days if it meets other standards and notifies Nasdaq of intent to cure via reverse split.
- No immediate effect on listing; stock continues trading on Nasdaq Capital Market under 'IBIO'.
- Company intends to monitor bid price and consider options including reverse stock split.

## SEC filing metadata
- accession: 0001558370-25-009992
- form_type: 8-K
- ticker: IBIO
- cik: 0001420720
- company_name: iBio, Inc.
- filed_at: 2025-08-01T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420720/000155837025009992/0001558370-25-009992-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420720/000155837025009992/ibio-20250729x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-009992
- JSON: https://secwatch.observer/filing/0001558370-25-009992.json
- Plain text: https://secwatch.observer/filing/0001558370-25-009992.txt

## Key facts
- Listing & Compliance Notices
  iBio, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: July 29, 2025, iBio, Inc. (the “Company”) received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the preceding 30 consecutive business days (June 13, 2025 to July 28, 2025), the Company’s common stock did not maintain a minimum closing bid price of $1.00 per share (the “Minimum Bid Price Requirement”), as required by Nasdaq Listing Rule 5550(a)(2). The notice has no immediate effect on the listing or trading of the Company’s common stock and the common stock will continue to trade on The Nasdaq Capital Market
  evidence_url: https://www.sec.gov/Archives/edgar/data/1420720/000155837025009992/0001558370-25-009992-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.